Literature DB >> 25481530

Fibrinolytic activity of endothelial cells from different venous beds.

Neil G Kumar1, Amanda Clark1, Elisa Roztocil1, Xzabia Caliste1, David L Gillespie1, John P Cullen2.   

Abstract

BACKGROUND: Little is known about the molecular biology of endothelial cells from different venous vascular beds. As a result, our treatment of deep vein thrombosis and pulmonary artery embolism remain identical. As an initial step in understanding venous thromboembolic disease in the trauma and surgical patients, this study sought to investigate the balance between coagulation and fibrinolysis in the pulmonary and deep venous vascular beds and how trauma might influence this balance.
MATERIALS AND METHODS: Confluent human iliac vein endothelial cells (HIVECs) and human pulmonary artery endothelial cells (HPAECs), were cultured in the absence or presence of tumor necrosis factor (TNFα; 10 ng/mL) for 24 h. The expression of mediators of coagulation and fibrinolysis were determined by Western blot analysis, and plasminogen activator activity was determined by a fibrin clot degradation assay.
RESULTS: After TNFα stimulation, there was decreased expression of endothelial protein C receptor and thrombomodulin in both HIVECs and HPAECs. TNFα stimulation increased urokinase plasminogen activator expression in both HIVECs and HPAECs. There was an increase in the expression of tissue plasminogen activator and plasminogen activator inhibitor-1 in response to TNFα in HPAECs, but not in HIVECs. There was significantly greater clot degradation in the presence of both the conditioned media and cell extracts from HIVECs, when compared with HPAECs.
CONCLUSIONS: HPAECs and HIVECs react differently in terms of fibrinolytic potential when challenged with a cytokine associated with inflammation. These findings suggest that endothelial cells from distinct venous vascular beds may differentially regulate the fibrinolytic pathway.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coagulation; Endothelial cells; Fibrinolysis; TNFα; Vascular beds

Mesh:

Substances:

Year:  2014        PMID: 25481530     DOI: 10.1016/j.jss.2014.09.028

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium.

Authors:  Ezequiel Álvarez; Beatriz Paradela-Dobarro; Sergio Raposeiras-Roubín; José Ramón González-Juanatey
Journal:  Br J Clin Pharmacol       Date:  2017-10-25       Impact factor: 4.335

2.  Thrombin stimulates increased plasminogen activator inhibitor-1 release from liver compared to lung endothelium.

Authors:  Benjamin R Huebner; Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Marguerite R Kelher; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  J Surg Res       Date:  2018-01-05       Impact factor: 2.192

Review 3.  Pulmonary Artery Thrombosis: A Diagnosis That Strives for Its Independence.

Authors:  Olga Porembskaya; Yana Toropova; Vladimir Tomson; Kirill Lobastov; Leonid Laberko; Viacheslav Kravchuk; Sergey Saiganov; Alexander Brill
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

Review 4.  Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).

Authors:  Amir Hossein Norooznezhad; Kamran Mansouri
Journal:  Microvasc Res       Date:  2021-05-19       Impact factor: 3.514

5.  An Unusually Rare but Interesting Co-Occurrence of Idiopathic Pulmonary Artery and Pulmonary Vein Thrombosis: A Case Report.

Authors:  Mohammadbagher Sharifkazemi; Gholamreza Rezaian; Mohammadhassan Nemati; Morteza Chehrevar
Journal:  CASE (Phila)       Date:  2019-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.